Vice President

Vice President, Head of Rare Disease Global Partnering is responsible to deliver on ambitious goals to establish solid early & mid stage Rare Disease pipeline. The Vice President, Head of Rare Disease Global Partnering is responsible for the activities from identification of targets in collaboration with External Innovation, due diligence, and execution of Rare Disease Business Development opportunities. He/ she ensures Business Development opportunities and transactions are aligned with Ipsen's overall corporate strategy as well as the needs of the Rare Disease franchises. The role entails a close working relationship with internal stakeholders and members of the Global Partnering & External Innovation team, as much as with the broader team members involved in business development activities and Rare Disease franchise, to coordinate sourcing and progression of all business development projects. He/She will also work in close coordination with Rare Disease franchise strategy head and GPPS team, as well as with the Global R&D to ensure fit with Ipsen's priorities. Furthermore, she/he works collaboratively with all members of the senior executive team. The Vice President, Head of Rare Disease Global Partnering is directly involved in establishing a robust reputation for Ipsen in business development overall and increase Ipsen's visibility of partner-of-choice for Rare Disease globally. This role is a member of the Global Partnering & External Innovation leadership team, and of the Ipsen's Global Leadership Team.

Responsibilities will include, but are not limited to, the following:

• Manage due diligence, structure and negotiate transactions, including in/out- licensing deals, product acquisitions, strategic partnerships, and M&A in Rare Disease, focused on assets that will enhance the company's portfolio.
• Collaborate with EVP, Chief Business Officer and stakeholder functions (including but not limited to C-level roles, country/regional leadership, Commercial Franchises, R&D, IP, Finance, Legal, Manufacturing and Corporate Strategy) to establish business development strategy & goals for Rare Disease that are aligned with overall business/corporate strategy and objectives.
• Ensure high-quality due diligence.
• Execute value-add deals.
• Lead contract negotiations and work with stakeholder functions to ensure high-quality contracts are negotiated and executed to protect future interests of Ipsen's business.
• Contribute to the strategic direction of corporate business development through analysis of evolving market and R&D/competitive landscape in Rare Disease and provide concise and accurate updates and documentation to senior management (and committees involving members from the Board of Directors when necessary) for deal review and decision-making.
• Contribute to the strategic direction of Rare Disease Franchise defining and steering Ipsen Rare Disease strategy
• Deliver accurate and timely updates, and provide customized support to the Executive Vice President, Chief Business Officer for regular review and decision making at senior management level.
• Maintain professional relationships with potential strategic partners and network with external companies and advisers in the industry including regular attendance at appropriate conferences and other industry events.

Education

• Master's degree in Science required.
• Advanced post-graduate degrees including Masters, Ph.D. in Chemistry, Biology or Medicine ideal; Master's in Finance or MBA desirable.

Experience

• The ideal candidate will be a top performing business development executive with minimum of 12-15 years industry experience from a global top biotech or medium-sized pharma company.
• This person will bring broad experience of business development in the R&D and commercial oncology context.
• The ideal candidate will bring a substantial deal sheet, including in- and out-licensing, M&A, product acquisitions/divestments, and strategic partnerships in the oncology space.
• With strong business and strategic acumen, the candidate will be experienced at structuring associated with biopharma deal making. S/he will be able to manage complex deals and perform solid market, company and product analysis and due diligence.
• The successful candidate will have proven project management and workflow delegation skills. They will have a good awareness of the biopharma ecosystem, including the deal- making landscape, and will have a track record of successfully securing deals in Rare Disease as a lead negotiator.
• Having excellent relationship and networking skills, this individual will likely have a well- established network in the pharma industry, particularly in the oncology space.
• Ideally, this person will bring international experience outside the US, and the candidate should truly understand the investor and biopharma market and have a substantial and relevant network of contacts. Sensitivity to (and familiarity with) the European and French business culture is an advantage.
• Experience with leading a team.

Languages

• Fluent English, French is a plus